---
$id: https://graph.org.ai/products/commodity/51171826
$type: Product
source: UNSPSC
code: "51171826"
title: "Alepride"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Alepride

**UNSPSC Code**: 51171826
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiemetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R6G1M06TPO. European Medicines Agency schedules Alepride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05309MIG. Alepride generally arises in the molecular formula C22H30CLN3O2. The term ALEPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, no. 10 1979, list 19.) ALEPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alepride under HS 29333999 and SITC 51574. As of Q4 2014, ALEPRIDE remains the US FDA Preferred Term for this commodity. Alepride bears US NLM identifiers UMLS ID C2697984 and NCI Concept Code C74450. SMILES: CLC1CC(C(=O)NC2CCN(CC3CCC=CC3)CC2)C(OCC=C)CC1N.

